V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220009223 | 220003741 | 1.5 | 57.5 | Disease modification (D) | 2016-09-19 | 2016-10-03 | FLUDARABINE | null | Y | 220036177 | CLADRIBINE + CYTARABINE + DAUNORUBICIN |
| 220009224 | 220003742 | null | 58.9 | Curative (C) | null | 2017-01-16 | FCR | Y | N | 220036184 | MITOXANTRONE |
| 220009225 | 220003743 | 1.8 | null | Palliative (P) | 2013-11-05 | 2013-11-20 | LENALIDOMIDE | N | N | 220036185 | LENALIDOMIDE |
| 220009226 | 220003744 | null | 63.6 | Curative (C) | null | 2013-04-12 | Ipilimumab | null | null | 220036187 | CYTARABINE + MITOXANTRONE |
| 220009227 | 220003745 | null | 57.9 | Curative (C) | 2016-09-02 | 2016-11-02 | Capecitabine | N | null | 220036189 | IDARUBICIN |
| 220009228 | 220003745 | 0 | 103 | Curative (C) | 2016-04-10 | 2016-04-10 | Cisplatin + Pemetrexed | N | N | 220036189 | CYCLOPHOSPHAMIDE |
| 220009229 | 220003746 | 1.77 | 64 | Curative (C) | 2014-03-20 | 2014-03-20 | Docetaxel | N | N | 220036193 | IDARUBICIN |
| 220009230 | 220003746 | 1.78 | null | Curative (C) | 2014-02-20 | 2014-02-20 | ECarboX | 01 | N | 220036193 | CYTARABINE + MITOXANTRONE |
| 220009231 | 220003746 | 1.8 | 82 | Palliative (P) | 2014-10-28 | 2014-10-28 | CISPLATIN + FLUOROURACIL | 02 | N | 220036193 | DAUNORUBICIN |
| 220009232 | 220003747 | null | 73 | Palliative (P) | 2013-04-27 | 2013-04-27 | Cytarabine intrathecal | N | N | 220036199 | IRINOTECAN + MDG |
| 220009233 | 220003748 | null | 85.1 | Disease modification (D) | null | 2017-10-28 | CHOP R - 21 days | N | null | 220036201 | RUXOLITINIB |
| 220009234 | 220003749 | 1.83 | 58 | Palliative (P) | null | 2015-08-14 | BOSUTINIB | N | N | 220036202 | FLUOROURACIL |
| 220009235 | 220003749 | 1.46 | 53.6 | Palliative (P) | 2017-04-27 | 2017-05-11 | Cisplatin + Docetaxel +Fluorouracil | N | N | 220036202 | LENALIDOMIDE |
| 220009236 | 220003750 | 0 | 59.9 | Curative (C) | 2015-03-29 | 2015-04-05 | BUSULFAN | N | N | 220036204 | ARSENIC TRIOXIDE |
| 220009237 | 220003751 | 1.77 | 77.1 | Disease modification (D) | 2014-12-27 | 2014-12-30 | Cisplatin | 02 | N | 220036205 | CHLORAMBUCIL |
| 220009238 | 220003751 | 1.67 | 97.7 | null | 2014-08-23 | 2014-08-23 | Arsenic Trioxide (consolidation) | N | N | 220036205 | RUXOLITINIB |
| 220009239 | 220003751 | 1.74 | 111 | Palliative (P) | 2014-08-05 | 2014-08-10 | CHOP R - 21 days | N | N | 220036205 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 220009240 | 220003751 | 1.69 | 10.9 | Curative (C) | null | 2016-08-28 | Irinotecan + Modified De Gramont | 99 | null | 220036205 | UKALL2014 |
| 220009241 | 220003751 | 1.73 | 66 | Palliative (P) | 2014-03-12 | 2014-03-13 | CAPECITABINE + CARBOPLATIN | 01 | N | 220036205 | CISPLATIN + ETOPOSIDE |
| 220009242 | 220003752 | 1.63 | 79.6 | Curative (C) | 2014-03-10 | 2014-03-10 | Cisplatin + Etoposide po&iv 3 day | 02 | null | 220036218 | BOSUTINIB |
| 220009243 | 220003753 | 1.78 | 101 | Curative (C) | 2015-05-26 | 2015-05-26 | UKALL14- Ph 1 Induction | N | N | 220036219 | UKALL2014 |
| 220009244 | 220003754 | 1.72 | 70.8 | Disease modification (D) | 2015-12-17 | 2015-12-30 | Carboplatin + Docetaxel | N | N | 220036225 | LANREOTIDE |
| 220009245 | 220003755 | null | null | null | null | 2016-08-02 | Cisplatin | null | null | 220036227 | SUNITINIB |
| 220009246 | 220003756 | 1.63 | 64.6 | Palliative (P) | 2017-09-16 | 2017-09-16 | LANREOTIDE | N | N | 220036228 | CAPECITABINE |
| 220009247 | 220003757 | 0 | 82.7 | Curative (C) | 2015-02-18 | 2015-02-21 | ATG + Busulfan + Fludarabine | N | N | 220036229 | ALEMTUZUMAB |
| 220009248 | 220003757 | null | 90.4 | Not known (9) | 2014-12-05 | 2014-12-12 | CYCLOPHOSPHAMIDE + LENALIDOMIDE | N | N | 220036229 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 220009249 | 220003757 | null | 80 | null | 2018-10-09 | 2018-11-06 | Erlotinib | 02 | N | 220036229 | FLUOROURACIL |
| 220009250 | 220003757 | 0 | null | Curative (C) | 2016-01-30 | 2016-02-04 | CAPECITABINE + TEMOZOLOMIDE | 2 | N | 220036229 | CISPLATIN |
| 220009252 | 220003758 | 1.63 | 72.2 | Palliative (P) | 2014-08-16 | 2014-08-16 | DAUNORUBICIN | 2 | N | 220036237 | CARBOPLATIN + PEMETREXED |
| 220009253 | 220003759 | null | 0 | Curative (C) | 2016-08-31 | 2016-08-31 | DABRAFENIB | 02 | N | 220036240 | IDARUBICIN + MITOXANTRONE + TRETINOIN |
| 220009254 | 220003759 | 1.56 | 121 | Curative (C) | 2015-02-21 | 2015-03-07 | Capecitabine + Cisplatin | 2 | N | 220036240 | ARSENIC TRIOXIDE |
| 220009255 | 220003759 | 1.67 | 67.2 | Curative (C) | 2015-04-23 | 2015-05-01 | BOSUTINIB | 02 | N | 220036240 | CISPLATIN + ETOPOSIDE |
| 220009256 | 220003759 | 1.62 | 52.85 | Curative (C) | null | 2017-04-05 | MITOXANTRONE + TRETINOIN | N | null | 220036240 | CISPLATIN |
| 220009257 | 220020522 | 0 | null | Curative (C) | 2015-11-30 | 2015-12-04 | Mitoxantrone | 02 | null | 220036245 | IDARUBICIN + MITOXANTRONE + TRETINOIN |
| 220009258 | 220020522 | null | 50.9 | Disease modification (D) | 2017-09-09 | 2018-02-01 | Methotrexate High Dose (3g/m2) | N | N | 220036245 | FBC |
| 220009259 | 220003760 | 1.8 | 113 | Palliative (P) | 2012-07-30 | 2012-09-05 | Fluorouricil + Folonic Acid (MdG) | N | N | 220036253 | ECF |
| 220009260 | 220003760 | null | null | Curative (C) | 2014-08-03 | 2014-08-03 | OCTREOTIDE | N | N | 220036253 | TRIPLE INTRATHECAL |
| 220009261 | 220003760 | null | 60 | Palliative (P) | 2016-04-05 | 2016-04-12 | Capecitabine | 02 | N | 220036253 | CISPLATIN + PEMETREXED |
| 220009262 | 220003760 | -1 | 78.1 | Curative (C) | null | 2015-12-22 | Triple / Double Intrathecal Therapy | null | null | 220036253 | FLUDARABINE + MELPHALAN |
| 220009263 | 220020523 | 1.66 | null | Disease modification (D) | null | 2015-10-16 | Capecitabine | null | null | 220036258 | BUSULFAN + CYCLOPHOSPHAMIDE |
| 220009264 | 220003761 | 1.83 | 66.2 | Disease modification (D) | 2014-02-25 | 2014-03-01 | DABRAFENIB | N | N | 220036260 | BOSUTINIB |
| 220009265 | 220003762 | 1.72 | null | Curative (C) | 2014-05-23 | 2014-06-02 | Carboplatin + Docetaxel | N | N | 220036261 | RUXOLITINIB |
| 220009266 | 220003762 | 0 | 77.1 | Not known (9) | 2018-06-19 | 2018-06-21 | Cytarabine intrathecal | 2 | N | 220036261 | CISPLATIN + FLUOROURACIL |
| 220009267 | 220003762 | 1.57 | 97.2 | Curative (C) | 2017-07-05 | 2017-07-06 | BUSULFAN + FLUDARABINE + METHOTREXATE | N | N | 220036261 | ARSENIC TRIOXIDE + ATRA |
| 220009268 | 220003762 | null | null | Disease modification (D) | 2013-04-29 | 2013-04-29 | Ipilimumab | N | N | 220036261 | RUXOLITINIB |
| 220009269 | 220003762 | 1.77 | 84.4 | Curative (C) | 2013-03-25 | 2013-08-23 | Docetaxel 75mg/m2 (21 day) | N | N | 220036261 | FLUDARABINE + MELPHALAN |
| 220009270 | 220003763 | 1.86 | 0 | Adjuvant (A) | 2016-12-30 | 2017-01-10 | CAPECITABINE + CISPLATIN + EPIRUBICIN | N | N | 220036275 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 220009271 | 220003764 | 1.73 | 83.4 | Not known (9) | null | 2015-09-30 | AML LI-1 Trial | N | N | 220036278 | CISPLATIN + PACLITAXEL |
| 220009272 | 220003765 | null | null | Curative (C) | null | 2017-07-05 | LANREOTIDE | null | null | 220036280 | ARSENIC TRIOXIDE + TRETINOIN |
| 220009277 | 220020525 | null | null | Curative (C) | 2014-03-26 | 2014-03-31 | CISPLATIN + ETOPOSIDE | null | null | 220036291 | CHOP R |